WhiteBook2_Part2 - 13
Results
In terms of disease categories, research to investigate Crohn's disease and ulcerative colitis
accounted for over a fifth of the priorities (22%), followed by research to investigate digestive
cancers which made up 17% of the priorities (Figure 3). Combined, research to investigate
alcohol-related liver disease and other chronic liver diseases accounted for 17% of the
priorities identified by the national societies, and viral hepatitis made up 4%. Research to
investigate diseases of the pancreas, and irritable bowel syndrome were also identified for
prioritisation by the societies, each making up 8% of the priorities.
Results were similar when investigating the percentage of societies that prioritised each
disease category, with Crohn's disease and ulcerative colitis research prioritised by 70% of the
societies, and digestive cancer research prioritised by 42% of the societies (plot in Appendix).
Figure 3.
Proportion of 120 research priorities identified by UEG national society members, by disease
category
20
15
10
5
Crohn's disease and ulcerative colitis (K50−K51)
Malignant neoplasms of digestive organs (C15−C26)
All diseases of the digestive system (K20−K93)
Other chronic liver diseases (K71−K77)
Diseases of pancreas (K85−K86, K87.1)
Irritable bowel syndrome (K58)
Viral hepatitis (B15−B19)
Gastritis, dyspepsia and other diseases of stomach and duodenum (K29−K31)
Other diseases of the digestive system (K90.1−K93)
Alcohol−related liver disease (K70)
Diseases of oesophagus (K20−K23)
Other diseases of gallbladder and biliary tract (K81−K83, K87.0)
Source: authors' compilation using sur vey data from UEG national society members .
Overall, Crohn's disease and ulcerative colitis drug therapy research was the most popular
disease and topic combination identified for prioritisation by the societies, accounting for
10% of the 120 research priorities. This was followed by digestive cancer prevention
research which made up 6% of the priorities.
White Book 2: Part 2
10
% of research priorities
WhiteBook2_Part2
Table of Contents for the Digital Edition of WhiteBook2_Part2
WhiteBook2_Part2 - 1
WhiteBook2_Part2 - 2
WhiteBook2_Part2 - 3
WhiteBook2_Part2 - 4
WhiteBook2_Part2 - 5
WhiteBook2_Part2 - 6
WhiteBook2_Part2 - 7
WhiteBook2_Part2 - 8
WhiteBook2_Part2 - 9
WhiteBook2_Part2 - 10
WhiteBook2_Part2 - 11
WhiteBook2_Part2 - 12
WhiteBook2_Part2 - 13
WhiteBook2_Part2 - 14
WhiteBook2_Part2 - 15
WhiteBook2_Part2 - 16
WhiteBook2_Part2 - 17
WhiteBook2_Part2 - 18
WhiteBook2_Part2 - 19
WhiteBook2_Part2 - 20
WhiteBook2_Part2 - 21
WhiteBook2_Part2 - 22
WhiteBook2_Part2 - 23
WhiteBook2_Part2 - 24
WhiteBook2_Part2 - 25
WhiteBook2_Part2 - 26
WhiteBook2_Part2 - 27
WhiteBook2_Part2 - 28
WhiteBook2_Part2 - 29
WhiteBook2_Part2 - 30
WhiteBook2_Part2 - 31
WhiteBook2_Part2 - 32
WhiteBook2_Part2 - 33
WhiteBook2_Part2 - 34
WhiteBook2_Part2 - 35
WhiteBook2_Part2 - 36
WhiteBook2_Part2 - 37
WhiteBook2_Part2 - 38
WhiteBook2_Part2 - 39
WhiteBook2_Part2 - 40
WhiteBook2_Part2 - 41
WhiteBook2_Part2 - 42
WhiteBook2_Part2 - 43
WhiteBook2_Part2 - 44
WhiteBook2_Part2 - 45
WhiteBook2_Part2 - 46
WhiteBook2_Part2 - 47
WhiteBook2_Part2 - 48
WhiteBook2_Part2 - 49
WhiteBook2_Part2 - 50
WhiteBook2_Part2 - 51
WhiteBook2_Part2 - 52
WhiteBook2_Part2 - 53
WhiteBook2_Part2 - 54
WhiteBook2_Part2 - 55
WhiteBook2_Part2 - 56
https://www.nxtbookmedia.com